Cleocin Phosphate Injection, Solution
Product Images NDC 71872-7165

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 71872-7165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (71872 7165 1 Pdp)

Label for Cleocin Phosphate clindamycin injection, USP 900 mg/6 mL (150 mg/mL) single dose vial. The injectable solution is indicated for intramuscular or intravenous use. The label includes storage instructions, dosage warnings, and manufacturer details, distributed by Medical Purchasing Solutions, LLC, Scottsdale, AZ.*

FDA Label Image

Chemical Structure (Cleocin Solution 01)

Chemical structure diagram of clindamycin phosphate, the active ingredient in Cleocin Phosphate injection solution.*

FDA Label Image

Logo (Cleocin Solution 02)

Cleocin Phosphate 150 mg/mL injection solution label for intramuscular and intravenous use. Distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, New York, NY. The label features the Pfizer Injectables logo along with distributor information.*

FDA Label Image

Figure 1 And 2 (Cleocin Solution 03)

An instructional illustration showing two steps: Fig. 1 depicts a hand pulling to remove a flip-off seal from the top of a vial; Fig. 2 shows a twist-off cap being lifted upward to open the vial. This diagram is likely related to vial closure removal for an injectable solution.*

FDA Label Image

Figure 3 And 4 (Cleocin Solution 04)

Illustrations showing hands opening a vial of Cleocin Phosphate injection solution, 150 mg/mL. Figure 3 depicts hand loosening the vial cap, and Figure 4 shows pulling the vial cap off. The vial is designed for intramuscular or intravenous use.*

FDA Label Image

Figure 5 And 6 (Cleocin Solution 05)

An instructional diagram showing two hands handling a vial. Figure 5 depicts the left hand holding the vial while the right hand places a stopper or cap on the top. Figure 6 shows the right hand pushing down or securing the cap on the vial, which is held by the left hand. The images likely illustrate part of the preparation or administration process of the injection.*

FDA Label Image

Logo (Cleocin Solution 05a)

Label for Cleocin Phosphate injection, solution, 150 mg/mL, for intramuscular and intravenous use. Distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, New York, NY 10017. The label features the Pfizer Injectables logo and distributor information.*

FDA Label Image

Principal Display Panel (900 mg/6 mL Vial Label)

Label for Cleocin Phosphate clindamycin injection, USP, 900 mg/6 mL (150 mg/mL) in a 6 mL single dose vial. The label indicates intramuscular or intravenous use, storage at controlled room temperature 20 to 25°C, and includes dosage instructions referencing accompanying prescribing information. Distributed by Pfizer Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.